Financials data is unavailable for this security.
View more
Year on year Tron Pharmaceuticals Inc 's net income fell 39.70% from a loss of 575.52k to a larger loss of 804.00k despite flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 53.15% to 71.42%.
Gross margin | 60.28% |
---|---|
Net profit margin | -110.51% |
Operating margin | -111.60% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2017, cash reserves at Tron Pharmaceuticals Inc fell by 252.51k. Cash Flow from Financing totalled 1.09m or 73.46% of revenues. In addition the company used 504.47k for operations while cash used for investing totalled 19.12k.
Cash flow per share | -0.0062 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0508 |
---|---|
Tangible book value per share | -0.0508 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0533 |
---|---|
Quick ratio | 0.0417 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼